The Spanner temporary prostatic stent is only FDA-cleared temporary stent for the male urethra, according to the release. It is placed in the prostatic urethra and opens the urethra as it passes through the prostate. The stent can also be an alternative to an indwelling Foley catheter.
“The Spanner is a synergistic addition to our suite of urology products for the diagnosis and treatment of men with symptoms of bladder outlet obstruction,” said Lee Brody, CEO of SRS Medical, in the release. “Along with our flagship CT3000 UroCuff exam, SRS continues to provide the urologist innovative tools for diagnosis and treatment in the office setting.”
SRS Medical is headquartered in North Billerica, Mass. AbbeyMoor Medical is headquartered in Parkers Prairie, Minn.
Related Articles on Acquisitions:
McKesson to Acquire PSS World Medical for $1.46B
Teleflex Completes Acquisition of Laryngeal Mask Manufacturer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.